Related Experiment Video
Updated: Mar 18, 2026

Use of the Operant Orofacial Pain Assessment Device OPAD to Measure Changes in Nociceptive Behavior
Published on: June 10, 2013
A methodological framework for constructing opioid agonist therapy episodes in administrative health data
Kiana Yazdani1,2, Cassidy Tam1, Christopher C Fisher1
1Epidemiology and Population Health Program, British Columbia Centre for Excellence in HIV/AIDS, 608-1081 Burrard Street, Vancouver, BC V6Z 1Y6 Canada.
Background:
Opioid Agonist Therapy (OAT) is the most effective intervention to reduce overdose risk, and administrative health data are now increasingly used to study OAT outcomes. However, current methods for constructing OAT episodes rely heavily on fixed permissible gaps and often overlook switches between medications, concurrent therapies, and the temporal complexity of dispensing patterns. We aimed to develop a robust episode-construction framework that more precisely reflects real-world OAT use within administrative health data.
Methods:
We analyzed OAT dispensations from people living with HIV in British Columbia (2010-2020). Episodes were constructed using three components: Allen's interval algebra, temporal margins ([Formula: see text]), and drug-specific permissible gaps. Allen's algebra characterized the temporal relation between two dispensations as meets (one starts when another ends), before (a positive gap), overlaps (partial overlap), starts (same start, earlier end), finishes (later start, same end), contains (one fully encloses another), or equals (identical start and end). Temporal margins distinguished short from long overlaps within the same OAT medication and differentiated switches from concurrent therapy when different OATs overlapped. Permissible gaps defined the maximum interruption allowed before episode discontinuation and were mapped onto Allen's before relation. Using this combined framework, we identified monotherapy (single-OAT use), transition (medication switches), multitherapy (concurrent OAT use), and transition-multitherapy episodes.
Results:
The before relation predominated across all OATs, particularly for methadone (99.43%). The equals relation was notably prevalent for buprenorphine (21.46%), slow-release oral morphine (20.87%), and injectable OAT (1.91%). To build monotherapy episodes, we applied [Formula: see text]=7 days, while [Formula: see text]=14 days differentiated transition from multitherapy episodes. We identified 10,386 episodes: 93.53% monotherapy, 3.72% transition, 2.27% multitherapy, and < 1% transition-multitherapy.
Conclusion:
We propose an episode-building framework based on Allen's relations, temporal margins, and permissible gaps that fine-tune OAT classification in administrative health data. The method is transferable to other settings and populations with suitable parameter adjustments.
Supplementary Information:
The online version contains supplementary material available at 10.1186/s44330-026-00064-9.
More Related Videos
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Analgesia and Pain Management
Opioid Analgesics: Morphine and Other Natural Cogeners
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Opioid Receptors: Overview
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...